Interaction between APOE Ɛ4 status, chemotherapy and endocrine therapy on cognitive functioning among breast cancer survivors: the CANTO-Cog longitudinal study
Mylène Duivon(Inserm), Florence Joly(Centre François Baclesse), Antonio Di Meglio(Inserm), Florence Lerebours(Institut Curie), Justine Lequesne(Centre Henri Becquerel), Christelle Lévy(Centre François Baclesse), Dominique Delmas(UniCancer Group), Emilie Thomas(Université Claude Bernard Lyon 1), Hélène Castel(Inserm), Olivier Rigal(Centre Henri Becquerel), Kathleen Van Dyk(University of California, Los Angeles), François Christy(Inserm), Inês Vaz-Luís(Inserm), Patricia A. Ganz(Los Angeles County Department of Public Health), Catherine Gaudin(UniCancer Group), Sandrine Boyault(Université Claude Bernard Lyon 1), Marie Lange(Inserm), Chayma Bousrih(Institut Gustave Roussy)
Cited by 3
Related Papers
Signatures of mutational processes in human cancer
|Nature|2013|10.1k
The Life History of 21 Breast Cancers
|Cell|2012|1.5k